Cyberounds Logo
December 15, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Direct-To-Consumer Genetic Testing
CME credit is no longer available for this conference.
Maxwell J. Mehlman, J.D.

Within the past 12 months, Professor Mehlman reports no commercial conflicts of interest.


Release Date: 04/28/2009
Termination Date: 04/28/2012

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • List the benefits and detriments of direct-to-consumer genetic testing
  • Discuss the ethical and legal problems that direct-to-consumer genetic testing may create for caregivers
  • Describe steps that caregivers might take to respond to these ethical and legal problems.

 
The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity